Prospera Financial Services Inc Johnson & Johnson Transaction History

Prospera Financial Services Inc

$3.82 Billion
Q3 2024

A detailed history of Prospera Financial Services Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Prospera Financial Services Inc holds 110,265 shares of JNJ stock, worth $16.9 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

110,265

Previous 93,837 17.51%

Holding current value

$16.9 Million

Previous $13.7 Million 30.29%

% of portfolio

0.47%

Previous 0.39%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$145.48 - $167.38 $2.39 Million - $2.75 Million	16,428 Added 17.51%	110,265 $17.9 Million
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $529,874 - $579,052	3,670 Added 4.07%	93,837 $13.7 Million
Q1 2024 Aug 13, 2024	BUY	$155.22 - $162.74 $71,401 - $74,860	460 Added 0.49%	94,297 $14.9 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $501,446 - $547,182	-3,444 Reduced 3.68%	90,167 $14.1 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $103,885 - $116,378	667 Added 0.72%	93,611 $14.6 Million
Q2 2023 Aug 08, 2023	BUY	$154.35 - $166.11 $2.26 Million - $2.44 Million	14,671 Added 18.74%	92,944 $15.4 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $3.56 Million - $4.24 Million	23,549 Added 43.03%	78,273 $12.1 Million
Q4 2022 Feb 08, 2023	SELL	$160.2 - $179.79 $2.06 Million - $2.31 Million	-12,847 Reduced 19.01%	54,724 $9.67 Million
Q3 2022 Oct 27, 2022	BUY	$161.33 - $179.52 $645,803 - $718,618	4,003 Added 6.3%	67,571 $11 Million
Q2 2022 Aug 08, 2022	BUY	$168.19 - $186.01 $241,857 - $267,482	1,438 Added 2.31%	63,568 $11.3 Million
Q1 2022 May 04, 2022	SELL	$158.14 - $179.59 $478,689 - $543,618	-3,027 Reduced 4.65%	62,130 $11 Million
Q4 2021 Feb 10, 2022	BUY	$155.93 - $173.01 $2.01 Million - $2.23 Million	12,907 Added 24.7%	65,157 $11.2 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $102,391 - $113,783	-634 Reduced 1.2%	52,250 $8.45 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $107,489 - $115,301	-674 Reduced 1.26%	52,884 $8.72 Million
Q1 2021 May 06, 2021	BUY	$153.07 - $170.48 $752,798 - $838,420	4,918 Added 10.11%	53,558 $8.81 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $6.66 Million - $7.65 Million	48,600 Added 121500.0%	48,640 $7.66 Million
Q3 2020 Nov 04, 2020	SELL	$140.38 - $153.83 $5.99 Million - $6.57 Million	-42,705 Reduced 99.91%	40 $6,000
Q2 2020 Aug 07, 2020	BUY	$128.81 - $155.51 $140,016 - $169,039	1,087 Added 2.61%	42,745 $6.01 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $471,344 - $653,071	4,241 Added 11.33%	41,658 $5.46 Million
Q4 2019 Feb 12, 2020	BUY	$127.5 - $146.44 $2 Million - $2.3 Million	15,720 Added 72.45%	37,417 $5.46 Million
Q3 2019 Oct 22, 2019	BUY	$126.95 - $142.14 $114,508 - $128,210	902 Added 4.34%	21,697 $2.81 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $2.11 Million - $2.32 Million	16,103 New	16,103 $2.08 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $615,355 - $676,774	4,692 Added 29.14%	20,795 $2.91 Million
Q1 2019 May 02, 2019	SELL	$125.72 - $139.79 $2.02 Million - $2.25 Million	-16,103 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $142,248 - $171,198	-1,158 Reduced 6.71%	16,103 $2.08 Million
Q3 2018 Oct 25, 2018	SELL	$121.58 - $142.88 $182,248 - $214,177	-1,499 Reduced 7.99%	17,261 $2.15 Million
Q2 2018 Jul 18, 2018	BUY	$119.4 - $131.76 $311,275 - $343,498	2,607 Added 16.14%	18,760 $2.29 Million
Q1 2018 Apr 12, 2018	SELL	$125.1 - $148.14 $26,646 - $31,553	-213 Reduced 1.3%	16,153 $2.08 Million
Q4 2017 Jan 24, 2018	SELL	$131.22 - $143.62 $101,564 - $111,161	-774 Reduced 4.52%	16,366 $2.29 Million
Q3 2017 Oct 11, 2017	BUY	$129.47 - $135.38 $2.22 Million - $2.32 Million	17,140	17,140 $2.24 Million

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Johnson & Johnson Transaction History